Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

View All Documentation

89127

Supelco

DL-Vanillactic acid lithium salt hydrate

≥97.0% (HPLC)

Synonym(s):

DL-3-(4-Hydroxy-3-methoxyphenyl)lactic acid lithium salt hydrate

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C10H12O5 · xLi+ · yH2O
CAS Number:
2475-56-1
Molecular Weight:
212.20 (free acid basis)
UNSPSC Code:
12352200
PubChem Substance ID:
329769703
NACRES:
NA.24

Quality Level

100

assay

≥97.0% (HPLC)

application(s)

clinical testing

format

neat

storage temp.

2-8°C

SMILES string

OC1=C(OC)C=C(CC(O)C(O)=O)C=C1.O.[Li]

InChI

1S/C10H12O5/c1-15-9-5-6(2-3-7(9)11)4-8(12)10(13)14/h2-3,5,8,11-12H,4H2,1H3,(H,13,14)

InChI key

SVYIZYRTOYHQRE-UHFFFAOYSA-N

Storage Class

11 - Combustible Solids

wgk_germany

WGK 3

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

M Tuchman et al.
Pediatric research, 23(6), 576-579 (1988-06-01)
Random urine samples were obtained from 31 patients with neuroblastoma (newborn to 8 yr of age) and from 100 children without this tumor (newborn to 10 yr). The urine samples were studied for the presence of sulfate and glucuronide conjugates
L Brun et al.
Neurology, 75(1), 64-71 (2010-05-28)
To describe the current treatment; clinical, biochemical, and molecular findings; and clinical follow-up of patients with aromatic l-amino acid decarboxylase (AADC) deficiency. Clinical and biochemical data of 78 patients with AADC deficiency were tabulated in a database of pediatric neurotransmitter
K Hyland et al.
Clinical chemistry, 38(12), 2405-2410 (1992-12-01)
Aromatic L-amino acid decarboxylase (EC. 4.1.1.28) deficiency is a newly described inborn error of metabolism that affects serotonin and dopamine biosynthesis. The major biochemical markers for this disease are increases of L-dopa, 3-methoxytyrosine, and 5-hydroxytryptophan in urine, plasma, and cerebrospinal

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service